生物信息学驱动识别与验证人颗粒细胞中调控子宫内膜异位症相关不孕的核心基因
本研究为探索性队列研究,利用GSE168214数据集识别差异表达基因,并在18例子宫内膜异位症相关不孕与76例输卵管性不孕患者的颗粒细胞中用qRT-PCR验证。共识别37个差异表达基因和5个核心基因,BTG2在子宫内膜异位症患者中表达降低(P=0.001)。作者认为BTG2有潜力作为预测卵母细胞发育潜能的新型无创生物标志物。
要点
- 在颗粒细胞中识别出BTG2、FOSB、NR4A1、NR4A2和NR4A3共5个核心基因。
- BTG2在子宫内膜异位症相关不孕患者颗粒细胞中表达降低(P=0.001)。
- BTG2 mRNA表达与基础FSH、hCG触发日LH负相关,与获卵率、囊胚数及囊胚形成率正相关。
核心结论
- 生物信息学驱动识别的颗粒细胞核心基因BTG2有潜力作为预测子宫内膜异位症相关不孕患者卵母细胞发育潜能的新型无创生物标志物。
研究设计与样本
- 探索性队列研究,研究对象为子宫内膜异位症相关不孕。
- 从基因表达综合数据库获取与子宫内膜异位症相关不孕相关的RNA测序数据集GSE168214以识别核心差异表达基因。
- 对18例子宫内膜异位症相关不孕患者和76例输卵管性不孕患者的颗粒细胞样本进行qRT-PCR检测,并分析其水平与IVF/卵胞浆内单精子注射结局的关系。
主要发现
- 共识别37个差异表达基因和5个核心基因(BTG2、FOSB、NR4A1、NR4A2和NR4A3)。
- 选择BTG2作为首选候选核心基因进行进一步验证。
- qRT-PCR检测的BTG2表达水平与RNA测序结果一致,显示在子宫内膜异位症患者中表达降低(P=0.001)。
- BTG2 mRNA表达与基础FSH负相关(aOR 0.671,95% CI 0.488-0.923;P=0.014),与hCG触发日LH负相关(aOR 0.765,95% CI 0.593-0.987;P=0.039)。
- BTG2 mRNA表达与获卵率正相关(aOR 1.012,95% CI 1.004-1.021;P=0.004),与形成的囊胚数正相关(aOR 1.080,95% CI 1.010-1.155;P=0.024),与囊胚形成率正相关(aOR 1.080,95% CI 1.010-1.155;P=0.001)。
关键数值与推荐
- 共识别37个差异表达基因和5个核心基因(BTG2、FOSB、NR4A1、NR4A2和NR4A3)。
- BTG2在子宫内膜异位症患者中表达降低(P=0.001)。
- BTG2 mRNA表达与基础FSH的aOR为0.671(95% CI 0.488-0.923;P=0.014)。
- BTG2 mRNA表达与hCG触发日LH的aOR为0.765(95% CI 0.593-0.987;P=0.039)。
- BTG2 mRNA表达与获卵率的aOR为1.012(95% CI 1.004-1.021;P=0.004);与囊胚数的aOR为1.080(95% CI 1.010-1.155;P=0.024);与囊胚形成率的aOR为1.080(95% CI 1.010-1.155;P=0.001)。
临床怎么用
- 作者认为,生物信息学驱动识别的颗粒细胞核心基因BTG2有潜力作为预测子宫内膜异位症相关不孕患者卵母细胞发育潜能的新型无创生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can bioinformatics-driven identification of hub genes in granulosa cells be used to predict oocyte developmental potential in patients with endometriosis (EMS)-related infertility? DESIGN: This was an exploratory cohort study on EMS-related infertility. An RNA sequencing dataset (GSE168214) related to EMS-related infertility was obtained from the Gene Expression Omnibus database to identify hub differentially expressed genes (DEG). Granulosa cell samples from 18 patients with EMS-related infertility and 76 patients with tubal-related infertility were further examined by quantitative real-time polymerase chain reaction (qRT-PCR) and analysed for their levels in relation to IVF/intracytoplasmic sperm injection outcomes. RESULTS: In total, 37 DEG and five hub genes (BTG2, FOSB, NR4A1, NR4A2 and NR4A3) were identified. BTG2 was selected as the preferred candidate hub gene for further validation. Expression levels of BTG2 detected by qRT-PCR were consistent with RNA sequencing results showing reduced expression in patients with EMS (P = 0.001). Moreover, BTG2 mRNA expression was negatively correlated with basal FSH [adjusted OR (aOR) 0.671, 95% CI 0.488-0.923; P = 0.014] and LH on the day of human chorionic gonadotrophin trigger (aOR 0.765, 95% CI 0.593-0.987; P = 0.039), and positively correlated with oocyte retrieval rate (aOR 1.012, 95% CI 1.004-1.021; P = 0.004), number of blastocysts formed (aOR 1.080, 95% CI 1.010-1.155; P = 0.024) and blastocyst formation rate (aOR 1.080, 95% CI 1.010-1.155; P = 0.001). CONCLUSION: Bioinformatics-driven identification of BTG2, one of the hub genes in granulosa cells, has the potential to serve as a novel non-invasive biomarker for predicting the oocyte developmental potential of patients with EMS-related infertility.
引用
- Luo J, Wang H, Zhou L, et al. Bioinformatics-driven identification and validation of hub genes regulating endometriosis-related infertility within human granulosa cells. Reprod Biomed Online. 2025. PMID: 40580573. doi:10.1016/j.rbmo.2025.104826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。